About
Technologies
Programs
Clinical Trials
Investors
News
Contact

About
Technologies
Programs
Clinical Trials
Investors
News
Contact

© 2023 © 2020 Genprex Inc. All Rights Reserved.

Tagged: Investors

Genprex to Participate in March Investor and Industry Conferences

March 8, 2023

Company to Showcase its Innovate Gene Therapy Programs in Oncology and Diabetes

Search for:

Categories

Blog Posts
Media Coverage
Press Releases

Recent Posts

In Search Of A Cure: The Growing Number Of Diabetics Is Inspiring A New Generation Of Therapies
Genprex to Present at Upcoming September Investor Conference
Genprex Appoints Suzanne Thornton-Jones as Senior Vice President, Regulatory Affairs
Genprex Granted FDA Orphan Drug Designation (ODD) for REQORSA® Immunogene Therapy for the Treatment of Small Cell Lung Cancer
Genprex Announces Closing of $7.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Archives

About

Overview
Company Management
Meet Our Team
Board of Directors
Scientific Advisory Board
Clinical Advisory Board
Careers
Contact Us

Clinical Trials

Pipeline
ONC-001
ONC-002
Acclaim-1
Acclaim-2
DIA-001
Expanded Access Policy

Investors

Overview
Company Profile
Stock Information
SEC Filings
Corporate Governance
Shareholder FAQ
Downloads
Events

News

Press Releases
Blog Posts
Media Coverage
Events
Email Alerts

Facebook
Twitter
LinkedIn

Home
Privacy Policy
Terms of Use